MedMira Reports Third Quarter Results FY2026
MedMira Reports Second Quarter Results FY2025
MedMira Reports First Quarter Results FY2026
MedMira Reports FY2025 Fourth Quarter and Year End Financial Results
Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada
MedMira Reports Second Quarter Results FY2025
MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
MedMira Reports Second Quarter Results FY2025
MedMira Announces Partnership with MediGroup Physician Services in the United States
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
MedMira Reports First Quarter Results FY2025
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
MedMira Reports FY2024 Fourth Quarter and Year End Financial Results
MedMira Announces the appointment of Vice President of Commercial Operations
MedMira Reports Third Quarter Results FY2024
MedMira Announces the Hire of Vice President of Business Development
MedMira Reports Second Quarter Results FY2024
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products
Corporate Update on Clinical Evaluation of MedMira's Products
MedMira Reports First Quarter Results FY2024
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
Update on MedMira's Regulatory Path in Canada and the USA
MedMira Closes New Equity Investment for Future Growth
MedMira Reports Third Quarter Results FY2021
MedMira Reports Second Quarter Results FY2021
Progress Update on MedMira's COVID-19 Product Family
MedMira Announces Product Update
MedMira Reports First Quarter Results FY2021